Product Information
CLOMIPRAMINE 50 MG CAPSULE is a generic product labeled by Major Pharmaceuticals, priced at $0.2513 per EA under NDC 00904703907. Its NADAC has been published 314 times since Aug 19, 2020.
FDA first approved this application on Dec 31, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Clomipramine Hydrochloride market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904703907
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLOMIPRAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074694FDA Approved
12/31/1996
TE Code
AB
On Market Since
12/31/1996
Pharmacological Classes
Price Statistics
The NADAC for CLOMIPRAMINE 50 MG CAPSULE has been published 314 times since Aug 19, 2020, and over the history we have for it it has declined 91.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2513 per EA |
|---|---|
| All-time high | $2.9030 (Sep 16, 2020) |
| All-time low | $0.2016 (May 22, 2024) |
| 52-week high | $0.2915 |
| 52-week low | $0.2257 |
| Median price | $0.3407 |
| Average price | $0.7472 |
| Largest weekly change | -56.5% (Nov 23, 2022) |
| Weeks tracked | 314 |
| Tracking since | Aug 19, 2020 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLOMIPRAMINE 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLOMIPRAMINE 50 MG CAPSULE, manufactured by Major Pharmaceuticals, is $0.2513 per EA (NDC 00904703907), effective Aug 19, 2026.
How has the price of CLOMIPRAMINE 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLOMIPRAMINE 50 MG CAPSULE has declined 91.3%. It has been tracked across 314 weekly CMS publications since Aug 19, 2020.
What are the highest and lowest recorded NADAC prices for CLOMIPRAMINE 50 MG CAPSULE?
Since Aug 19, 2020, the NADAC for CLOMIPRAMINE 50 MG CAPSULE has ranged from a low of $0.2016 (May 22, 2024) to a high of $2.9030 (Sep 16, 2020), with a median of $0.3407 per EA.
Are there cheaper alternatives to CLOMIPRAMINE 50 MG CAPSULE?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLOMIPRAMINE 50 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures CLOMIPRAMINE 50 MG CAPSULE?
CLOMIPRAMINE 50 MG CAPSULE (NDC 00904703907) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.